WuXi Bi­o­log­ics serves up $1.4B ex­pan­sion of re­search and man­u­fac­tur­ing cen­ter in Sin­ga­pore

3 years ago
Pharma
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er de­buts new ‘Menopause’ pod­cast sea­son; Pfiz­er, Mod­er­na nab top spots on in­no­va­tion ...

3 years ago
Pharma
Marketing

Phar­mas change up lo­gos in June to sig­nal LGT­BQ+ sol­i­dar­i­ty, but ex­perts call for push be­yond ‘rain­bow wash­ing’

3 years ago
Pharma
Marketing

San Fran­cis­co cell ther­a­py play­er lays off 94 staffers as it awaits da­ta on lead can­di­date

3 years ago
People
Cell/Gene Tx

In­cyte nabs sec­ond ap­proval with JAK in­hibitor cream for vi­tili­go

3 years ago
Pharma
FDA+

Af­ter abor­tion rul­ing, biotechs be­hind nov­el con­tra­cep­tives say tide is turn­ing on in­sur­ance cov­er­age

3 years ago
In Focus

As the pan­dem­ic high wanes, In­ovio chops head­count again while chas­ing Covid win

3 years ago
People
R&D

Look­ing to climb out of bear mar­ket and FDA hur­dles, Sum­mit of­fers up $100M worth of stock

3 years ago
Financing
Pharma

Apel­lis nabs pri­or­i­ty re­view for ge­o­graph­ic at­ro­phy pitch; Bris­tol My­ers ex­tends of­fer time­line on Turn­ing Point ...

3 years ago
News Briefing

Mi­cro­cap Viking gets a re­prieve as FDA lifts hold on PhII study for rare meta­bol­ic dis­or­der

3 years ago
FDA+

In bid to avoid im­munother­a­py tox­i­c­i­ties, Car­tog­ra­phy charts a course to­ward modal­i­ty-ag­nos­tic drugs

3 years ago
Financing
Startups

Short­ly af­ter sell­ing Sier­ra to GSK, Stephen Dil­ly heads to en­zyme en­gi­neer Codex­is as new CEO

3 years ago
People

Lyn­parza fails a PhI­II test in col­orec­tal can­cer, cut­ting off big R&D av­enue for Mer­ck and As­traZeneca

3 years ago
R&D
Pharma

Safe­ty scare cleared and ear­ly da­ta in hand, Ul­tragenyx dish­es out $75M to buy rare dis­ease part­ner

3 years ago
Deals

Fol­low­ing Lux­tur­na and slate of eye dis­ease ap­provals, Roche adds an­oth­er oph­thal­mol­o­gy part­ner for AAV gene ...

3 years ago
Startups
Deals

Ei­sai shut­ters on­col­o­gy unit, cuts around 80 jobs

3 years ago
Pharma

Bio­gen sees more than 330 de­par­tures from MA-based sites since last sum­mer

3 years ago
Pharma

GSK nets a deal with Cana­di­an gov­ern­ment for flu vac­cine man­u­fac­tur­ing

3 years ago
Pharma
Manufacturing

Khloé Kar­dashi­an strikes again with mi­graine med Nurtec mar­ket­ing in ‘all in one’ push

3 years ago
Pharma
Marketing

Mil­li­pore­Sig­ma us­es DOD funds to ex­pand Wis­con­sin-based man­u­fac­tur­ing site

3 years ago
Manufacturing

Phar­ma R&D spend­ing in the US more than dou­bles in a decade, PhRMA sur­vey finds

3 years ago
Pharma

Eu­rope buys 54,000 more dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine as cas­es in­crease

3 years ago
Pharma

Am­gen ex­pands Sto­ryCorps on­col­o­gy cam­paign with celebri­ty ac­tor, preps for up­com­ing health eq­ui­ty sto­ries

3 years ago
Pharma
Marketing

GSK's con­sumer health unit Ha­le­on off to a rough start

3 years ago
Pharma
First page Previous page 494495496497498499500 Next page Last page
A service from the Financial Times